BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38094457)

  • 21. Retracted: Prognostic Value of Stem Cell Index-Related Characteristics in Primary Hepatocellular Carcinoma.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9850917. PubMed ID: 37502512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9806936. PubMed ID: 37502585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gamma glutamyl transpeptidase as a prognostic biomarker in hepatocellular cancer patients especially with >5 cm tumors, treated by liver transplantation.
    Ince V; Carr BI; Bag HG; Koc C; Usta S; Ersan V; Baskiran A; Sahin TT; Yilmaz S
    Int J Biol Markers; 2020 Jun; 35(2):91-95. PubMed ID: 32436751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9819147. PubMed ID: 37808149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9809678. PubMed ID: 37538093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retracted: Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9808126. PubMed ID: 38550199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic significance of serum gamma-glutamyl transferase before transcatheter arterial chemoembolization in patients with hepatitis C virus-related hepatocellular carcinoma].
    Chang ZF; Liu FY; Duan F; Wang ZJ; Yan JY; Wang MQ
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):202-5. PubMed ID: 26988826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C-Registry.
    Tacke F; Klinker H; Boeker KHW; Merle U; Link R; Buggisch P; Hüppe D; Cornberg M; Sarrazin C; Wedemeyer H; Berg T; Mauss S;
    Hepatol Commun; 2022 Sep; 6(9):2488-2495. PubMed ID: 35666055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retracted: Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
    Markers D
    Dis Markers; 2023; 2023():9841329. PubMed ID: 37538089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of liver enzyme abnormalities in acute graft-versus-host disease after bone marrow transplantation].
    Mo XD; Xu LP; Liu KY; Liu DH; Chen H; Wang FR; Zhang XH; Han W; Chen YH; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):400-4. PubMed ID: 20646414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated ALT and GGT predict all-cause mortality and hepatocellular carcinoma in Taiwanese male: a case-cohort study.
    Hernaez R; Yeh HC; Lazo M; Chung HM; Hamilton JP; Koteish A; Potter JJ; Brancati FL; Clark JM
    Hepatol Int; 2013 Oct; 7(4):1040-9. PubMed ID: 26202033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retracted: Cuproptosis-Related Genes CDK1 and COA6 Involved in the Prognosis Prediction of Liver Hepatocellular Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9786174. PubMed ID: 38077938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retracted: The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9848563. PubMed ID: 37829384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests.
    Kukuk GM; Schaefer SG; Fimmers R; Hadizadeh DR; Ezziddin S; Spengler U; Schild HH; Willinek WA
    Eur Radiol; 2014 Oct; 24(10):2482-90. PubMed ID: 25030459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retracted: A Computational Framework to Identify Transcriptional and Network Differences between Hepatocellular Carcinoma and Normal Liver Tissue and Their Applications in Repositioning Drugs.
    International BR
    Biomed Res Int; 2023; 2023():9832414. PubMed ID: 38075310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of preoperative serum gamma-glutamyltranspeptidase in patients with hepatocellular carcinoma after hepatectomy.
    Fu S; Guo Z; Li S; Kuang M; Hu W; Hua Y; He X; Peng B
    Tumour Biol; 2016 Mar; 37(3):3433-40. PubMed ID: 26449826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retracted: Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies.
    BioMed Research International
    Biomed Res Int; 2018; 2018():4560161. PubMed ID: 29854758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevation of serum GGT and LDH levels, together with higher BCLC staging are associated with poor overall survival from hepatocellular carcinoma: a retrospective analysis.
    Yang Z; Ye P; Xu Q; Lu Y; Tang B; Wang Q; Chen S; Chen X
    Discov Med; 2015 Jun; 19(107):409-18. PubMed ID: 26175398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retracted: Preliminary Evaluation of Artificial Intelligence-Based Anti-Hepatocellular Carcinoma Molecular Target Study in Hepatocellular Carcinoma Diagnosis Research.
    International BR
    Biomed Res Int; 2023; 2023():9850584. PubMed ID: 37475788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retracted: Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9817406. PubMed ID: 37564537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.